The 21st century has, in many ways, been shaped by the rapid advancements in technology and medicine. As we edge into the next decade, one of the most profound shifts on the horizon concerns the CPG and “Big Food” industries. Their challenge? Adapting to the changing consumer behaviors driven by the rising adoption of GLP-1 class pharmaceuticals.
This member brief is designed exclusively for Executive Members
, to make membership easy, you can click below and gain access to hundreds of reports, our DTC Power List, and other tools to help you make high level decisions.